Loading course details...
Your trusted destination for CME, CPD & Medical Education across the Middle East.
The International Conference on Clinical Trials in Diabetes Research (ICCTDR-26) is a hybrid event focusing on the latest research findings and knowledge dissemination in the field. It aims to bring together researchers, academics, and policymakers to foster collaboration and advance diabetes research.
Join the International Conference on Clinical Trials in Diabetes Research (ICCTDR-26) in Riyadh, Saudi Arabia, or virtually, from October 3rd to 4th, 2026. This premier event is dedicated to the systematic dissemination of the latest research and knowledge for the advancement of diabetes clinical trials. The conference agenda is designed to unite policymakers, academic leaders, and research professionals to overcome institutional barriers and promote high-level collaboration. Participants will benefit from illuminating lectures, insightful discussions, informative panel discussions, and workshops, all aimed at securing the future of diabetes research and improving professional practice globally.
Exploring flexible trial methodologies that allow for modifications based on interim data analysis.
Utilizing data from real-world clinical practice to supplement traditional trial findings.
Leveraging technology to conduct trials remotely, enhancing patient access and data collection.
Investigating new therapeutic agents and their mechanisms of action in treating diabetes.
Assessing the efficacy and safety of combining different classes of antidiabetic drugs.
Tailoring pharmacotherapy based on individual patient genetics, biomarkers, and lifestyle.
Examining the role of apps, sensors, and telehealth in promoting lifestyle changes.
Reviewing the latest evidence on dietary patterns for diabetes prevention and management.
Implementing psychological strategies to improve adherence to treatment and lifestyle recommendations.
Measuring the impact of treatments on patients' quality of life and symptoms.
Evaluating the cardiovascular safety and benefits of new diabetes therapies.
Assessing the effects of interventions on nephropathy, retinopathy, and neuropathy.
Developing strategies to ensure trial populations are representative of the broader patient community.
Building trust and partnerships with communities to improve trial participation.
Designing trials that minimize patient burden and maximize engagement and retention.
Secure your seat and earn full credit eligibility with encrypted checkout.
Secure payment processing & PCI-aligned flow